FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> HPV   Johns Hopkins
Syndicate content

MediGene News

Most Popular MediGene Story

MediGene, Johns Hopkins join on HPV vax research

MediGene, a Martinsried/Munich-based biotech, and The Johns Hopkins University will work together to create HPV vaccine candidates using the German firm's AAVLP platform. The preclinical program uses Read more...

MediGene Press Releases

  • MediGene and Johns Hopkins University Sign Development Collaboration for First Vaccine Candidates from MediGene's AAVLP platform
  • MediGene AG (DX:MDG) Spins Out mTCR Program - Independent Company Immunocore Limited Founded
  • PRESS RELEASE: MediGene Raises € 15,6 Million in Private Placement with Santo Holding GmbH

Latest Headlines